Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
US Market
Holding SONN?
Track your performance easily

Sonnet BioTherapeutics Holdings (SONN) Financial Statements

433 Followers

Sonnet BioTherapeutics Holdings Financial Overview

Sonnet BioTherapeutics Holdings's market cap is currently ―. The company's EPS TTM is $-3.024; its P/E ratio is -0.29; Sonnet BioTherapeutics Holdings is scheduled to report earnings on December 12, 2024, and the estimated EPS forecast is $-0.63. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--$ 18.60K$ -10.55K$ 36.85K
Gross Profit--$ 18.63K$ -10.55K$ 36.85K
EBIT$ -3.51M$ 8.10M$ -1.28M$ -3.72M$ -3.95M
EBITDA$ -3.48M$ 8.12M$ -1.26M$ -3.71M$ -3.93M
Net Income Common Stockholders$ -3.51M$ 365.43K$ -1.17M$ -3.72M$ -3.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.60M$ 3.80M$ 3.00M$ 2.27M$ 7.02M
Total Assets$ 5.80M$ 5.91M$ 5.34M$ 5.43M$ 10.03M
Total Debt$ 150.19K$ 168.94K$ 186.69K$ 203.91K$ 220.63K
Net Debt$ -3.45M$ -3.63M$ -2.81M$ -2.07M$ -6.80M
Total Liabilities$ 3.18M$ 2.86M$ 2.77M$ 5.66M$ 6.62M
Stockholders Equity$ 2.62M$ 3.05M$ 2.57M$ -225.98K$ 3.42M
Cash Flow-
Free Cash Flow$ -3.07M$ 723.79K$ -3.09M$ -4.56M$ -6.17M
Operating Cash Flow$ -3.07M$ 723.79K$ -3.09M$ -4.56M$ -6.17M
Investing Cash Flow$ -12.00K--$ -170.00K$ -12.00K
Financing Cash Flow$ 2.85M$ 41.00K$ 3.84M$ -17.70K$ 1.81M
Currency in USD

Sonnet BioTherapeutics Holdings Earnings and Revenue History

Sonnet BioTherapeutics Holdings Debt to Assets

Sonnet BioTherapeutics Holdings Cash Flow

Sonnet BioTherapeutics Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis